Publications
- Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data2015 | First Faculty of Medicine
- Contribution of the Beta-ureidopropionase (UPB1) gene alterations to the development of fluoropyrimidine-related toxicity2012 | First Faculty of Medicine
- Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients.2010 | First Faculty of Medicine
- Lack of large intragenic rearrangements in dihydropyrimidine dehydrogenase (DPYD) gene in fluoropyrimidine-treated patients with high-grade toxicity.2009 | First Faculty of Medicine
- Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy2009 | First Faculty of Medicine
- Prediction of toxicity fluoropyrimids used in the treatment of cancer2009 | First Faculty of Medicine
- Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy2009 | Publication without faculty affiliation
- Prediction of toxicity fluoropyrimids used in the treatment of cancer2009 | Publication without faculty affiliation
- Analysis of mutations and polymorphisms of dihydropyrimidine dehydrogenase (DPD) in prediction of toxicity caused by flouropyrimidines2007 | First Faculty of Medicine
- Fluoropyrimidines toxicity prediction based on mutation analysis of dihydropyrimidin dehydrogease (DPD) coding sequencePublication without faculty affiliation
Loading network view...
